The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial

Clinical trial NCT07197034 · TERMINATED

Trial details

NCT number: NCT07197034
Sponsor: Aardvark Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperphagia Prader-Willi Syndrome Hyperphagia in Prader-Willi Syndrome

Start date: 2024-07-23
Primary completion: 2026-04-15
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.